Avidity biosciences to participate in upcoming investor conferences

San diego , aug. 30, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating at the following upcoming conferences: 2023 wells fargo healthcare conference on september 6 at 5:45 a.m. pt/8:45 a.m.
RNA Ratings Summary
RNA Quant Ranking